Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Raetz

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
JAMA Network Open|December 29, 2022
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic LeukemiaWenjian Yang, Seth E Karol, Keito Hoshitsuki, et al.
Journal of the National Cancer Institute|May 16, 2022
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic LeukemiaXujie Zhao, Maoxiang Qian, Charnise Goodings, et al.
Blood|September 5, 2008
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemiaJun J Yang, Deepa Bhojwani, Wenjian Yang, et al.
Blood Advances|May 17, 2023
Flow cytometric assessment of leukemia-associated monocytes in childhood B-cell acute lymphoblastic leukemia outcomeGloria P Contreras Yametti, Nikki A Evensen, Jennifer M Schloss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Reply to C.T. Matava et alSarah Alexander, John A Kairalla, Sumit Gupta, et al.
JAMA|March 2, 2021
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical TrialPatrick A Brown, Lingyun Ji, Xinxin Xu, et al.
Pediatric Blood & Cancer|January 5, 2026
Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932Lyn M Balsamo, John A Kairalla, Emily Hibbitts, et al.
Pediatric Blood & Cancer|December 18, 2020
Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experienceP Pallavi Madhusoodhan, Joanna Pierro, Jordan Musante, et al.
Blood|October 27, 2020
Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populationsWenjian Yang, Meenakshi Devidas, Yiwei Liu, et al.
Cancer|December 22, 2017
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
JAMA Network Open|December 29, 2022
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic LeukemiaWenjian Yang, Seth E Karol, Keito Hoshitsuki, et al.
Journal of the National Cancer Institute|May 16, 2022
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic LeukemiaXujie Zhao, Maoxiang Qian, Charnise Goodings, et al.
Blood|September 5, 2008
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemiaJun J Yang, Deepa Bhojwani, Wenjian Yang, et al.
Blood Advances|May 17, 2023
Flow cytometric assessment of leukemia-associated monocytes in childhood B-cell acute lymphoblastic leukemia outcomeGloria P Contreras Yametti, Nikki A Evensen, Jennifer M Schloss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Reply to C.T. Matava et alSarah Alexander, John A Kairalla, Sumit Gupta, et al.
JAMA|March 2, 2021
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical TrialPatrick A Brown, Lingyun Ji, Xinxin Xu, et al.
Pediatric Blood & Cancer|January 5, 2026
Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932Lyn M Balsamo, John A Kairalla, Emily Hibbitts, et al.
Pediatric Blood & Cancer|December 18, 2020
Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experienceP Pallavi Madhusoodhan, Joanna Pierro, Jordan Musante, et al.
Blood|October 27, 2020
Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populationsWenjian Yang, Meenakshi Devidas, Yiwei Liu, et al.
Cancer|December 22, 2017
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.
Pageof 16